GFAP and prion disease: Using Tg(Gfap-luc) mice (46), which express luciferase under the Gfap promoter, it is possible to track the progression of gliosis by live animal bioluminescence imaging (BLI) throughout the course of prion disease (68) and to obtain time-series data on the effect of drug treatment(31).